1.
Eur J Gynaecol Oncol
; 34(4): 353-4, 2013.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24020147
RESUMO
Signet-ring cell adenocarcinoma is a rare subtype of the uterine cervix; thus there are no guidelines and the prognosis is unknown. There seems to be a significant role for reporting the treatment and outcome of this rare disease in order to establish guidelines and to assist in decision-making. However, treatment should be tailored to each patient according to clinical status and disease stage. Excluding extra-genital origin is mandatory, as it will change treatment management considerably.